Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exosome-based and Machine-learning-powered Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring

NCT07700992 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT07700992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07700992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exosome-based and Machine-learning-powered Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
June 3, 2026
Completion date
January 30, 2032
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial pancreatic cancer, familial pancreatic carcinoma, hereditary pancreatic cancer, hereditary pancreatitis, intraductal papillary mucinous neoplasm, pancreas adenocarcinoma, pancreas cancer, pancreas cyst, pancreas neoplasm, pancreatic neoplasms